Stock search

Ticker or company name

Compare stocks

Market: US

  • HUMHumana
  • IDXXIdexx Laboratories
  • BDXBecton Dickinson

Add stock

Ticker or company

Summary

HUM
Humana
$461,25Up +2,50%
Year: Up +90%
61/100Ratio would watch
Open stock page
IDXX
Idexx Laboratories
$700,65Down −0,51%
Year: Up 0%
83/100Best scoreRatio would consider buying
Open stock page
BDX
Becton Dickinson
$216,47Down −0,72%
Year: Up +44%
38/100Ratio would not consider buying
Open stock page

Verdict

IDXX has the best score (83). HUM grows revenue the fastest. BDX is the cheapest by forward P/E. HUM has the lowest debt load. IDXX has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckHUM5 ✓ 1 — 3 ✕IDXX7 ✓ 1 — 1 ✕BDX2 ✓ 2 — 4 ✕
P/E vs its history44,047,251,8
P/E vs industry44,047,251,8
Forward P/E26,933,514,9
Revenue growth, YoY+22,0%+11,9%−2,6%
EPS growth, YoY−3,6%+17,7%−39,4%
Net margin0,8%25,4%4,5%
Net debt / EBITDA−4,50,12,9
Free cash flow$3,14 bn$1,30 bnn/a—
Share count over a year+0,9%−2,0%−4,2%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterHUMTTMIDXXTTMBDXTTMIndustry medianTTM
P/E TTM ↓Best: 44,047,2Worst: 51,825,1
Forward P/E ↓26,9Worst: 33,5Best: 14,916,2
PEG ↓Best: 1,9Worst: 2,8−27,12,2
P/S TTM ↓Best: 0,4Worst: 12,02,92,2
EV/EBITDA ↓20,0Worst: 33,9Best: 16,417,3
P/FCF ↓Best: 11,0Worst: 42,921,519,5

Price, %

  • HUMn/a
  • IDXXn/a
  • BDXn/a

Returns

Best WorstNo mark — in between

PeriodHUMIDXXBDX
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

HUMIDXXBDX
Share of “buy”59%Best: 67%Worst: 57%
Beat the forecast4 of 44 of 44 of 4
Average “surprise”Best: +9,4%+3,7%Worst: +2,2%
Insiders over 12 monthssales $2,43 msales $58,4 msales $3,38 m

Details are on each stock page.